B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 (Q39068): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-2A70.1
@@ Property / Canary Token: dki-india-2A70.1 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+C81-C96
@@ Property / Linked ICD 10: C81-C96 / rank @@
+Normal rank

Latest revision as of 04:22, 13 August 2026

A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.

Language	Label	Description	Also known as
default for all languages	2A70.1
English	B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1	A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.